|
|
|
51-200 employees
View all
|
|
biotechnology
|
|
The Bennet Building,Cambridge,GB
|
|
Kymab is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform available.Kymab’s platform has been designed to maximise the diversity of human antibodies produced in response to immunisation with antigens. Selecting from a broad diversity of fully human antibodies assures the highest probability of finding drug candidates with best-in-class characteristics quickly and efficiently. Kymab is using the platform for its internal drug discovery programmes and in partnership with pharmaceutical companies. Kymab was founded in 2010 and has raised over US$220m of equity financing. It has an experienced management team with a successful track record in drug discovery and development and a broad pipeline of therapeutic antibody programmes in immune-oncology, auto-immunity, haematology, infectious disease and other areas.
|
Kymab Ltd Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
92.86%
|
The widely used Kymab Ltd email format is {first}.{last} (e.g. [email protected]) with 92.86% adoption across the company.
To contact Kymab Ltd customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.